WuXi Biologics to sell Ireland vaccine facility to Merck for $500 million
Jan 6 (Reuters) - WuXi Biologics 2269.HK said on Monday its unit, WuXi Vaccines Ireland, will sell its vaccine facility in Ireland to Merck MRK.N for about $500 million. (Reporting by Sneha S K; Editing by Krishna Chandra Eluri) ((Sneha.SK@thomsonreuters.com;))
Recent news on WuXi Biologics (Cayman)
See all newsHong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
CanSino leads HK-listed vaccine makers lower as BioNTech halts mRNA trial
WuXi Biologics H1 net profit up on margin expansion
Brief: WuXi Biologics Logs HY Net Profit Attributable RMB 2,439.8 Mln